<?xml version="1.0" encoding="UTF-8"?>
<ref id="b99-ir-2019-09155">
 <label>99</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reddy</surname>
    <given-names>KR</given-names>
   </name>
   <name>
    <surname>Beavers</surname>
    <given-names>KL</given-names>
   </name>
   <name>
    <surname>Hammond</surname>
    <given-names>SP</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>JK</given-names>
   </name>
   <name>
    <surname>Falck-Ytter YT; American Gastroenterological Association</surname>
    <given-names>Institute</given-names>
   </name>
  </person-group>
  <article-title>American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy</article-title>
  <source>Gastroenterology</source>
  <year>2015</year>
  <volume>148</volume>
  <fpage>215</fpage>
  <lpage>219</lpage>
  <pub-id pub-id-type="pmid">25447850</pub-id>
 </element-citation>
</ref>
